Trendlines associate company in talks to be sold for US$16m
Proposed sale will result in delisting of ETView from Tel Aviv bourse
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CATALIST-listed Trendlines Group said on Friday that its 26.46 per cent-owned associated company ETView Medical could soon be acquired for US$16 million - in what would be the medical tech (medtech) incubator's first exit of a portfolio company since it listed on the Singapore Exchange in November 2015.
Trendlines said that ETView, which manufactures airway visualisation products for medical professionals, has reported to the Tel Aviv Stock Exchange (TASE) that it is in an advanced stage of negotiations with an international company, with the intention to sign a definitive agreement "as soon as possible" to sell ETView to the international company.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar
